Erlotinib 100 mg/1

Erlotinib 100 mg tablets are a targeted therapy used in cancer treatment. This oral medication, manufactured by Teva Pharmaceuticals USA, Inc., is designed to inhibit specific proteins involved in cancer cell growth.

Erlotinib is primarily used in the treatment of certain types of cancer, such as non-small cell lung cancer and pancreatic cancer. It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. This medication is often prescribed as part of a broader treatment plan.

Common effects of Erlotinib may include skin rash, diarrhea, and fatigue. Some individuals may also experience appetite loss, nausea, or dry skin. These effects can vary in severity and may not affect everyone who takes the medication.

Erlotinib should be handled with care and stored as directed. It is important to follow the advice of a healthcare provider regarding its use. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider before taking this medication.

Erlotinib may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, consuming grapefruit or grapefruit juice while taking Erlotinib should be avoided.